The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 06, 2017

Filed:

Jun. 29, 2016
Applicants:

Array Biopharma Inc., Boulder, CO (US);

Genentech, Inc., South San Francisco, CA (US);

Inventors:

James F. Blake, Boulder, CO (US);

Adam Cook, Boulder, CO (US);

John Gaudino, Boulder, CO (US);

Indrani W. Gunawardana, Boulder, CO (US);

Erik James Hicken, Boulder, CO (US);

Kevin W. Hunt, Boulder, CO (US);

Michael Lyon, Boulder, CO (US);

Andrew T. Metcalf, Boulder, CO (US);

Peter J. Mohr, Boulder, CO (US);

David A. Moreno, Boulder, CO (US);

Brad Newhouse, Boulder, CO (US);

Li Ren, Boulder, CO (US);

Jacob Schwarz, South San Francisco, CA (US);

Huifen Chen, South San Francisco, CA (US);

Lewis Gazzard, South San Francisco, CA (US);

Jane Schmidt, South San Francisco, CA (US);

Steve Do, South San Francisco, CA (US);

Assignees:

Array BioPharma Inc., Boulder, CO (US);

Genentech, Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 45/06 (2006.01); A61K 31/5377 (2006.01); A61K 31/506 (2006.01); A61K 31/444 (2006.01); C07D 487/04 (2006.01); C07D 519/00 (2006.01); A61K 31/55 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/444 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 31/55 (2013.01); A61K 45/06 (2013.01); C07D 487/04 (2013.01); C07D 519/00 (2013.01);
Abstract

Compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such diseases, or associated pathological conditions are disclosed.


Find Patent Forward Citations

Loading…